Morgan Stanley (MS) 19.67 -0.68

Morgan Stanley
(MS) 19.67 -0.68

Last Trade:	19.66	Day Range:	19.50 - 19.99
Trade Time:	04:02PM	52wk Range:	11.58 - 31.04
Prev. Close:	20.34	Market Cap:	37.89B
Open:	19.99	Div Yield:	1.02
Volume:	21980642	PE:	160
EPS:	1.26

The Latest On MS

UPDATE: Collins Stewart Downgrades Morgan Stanley to Hold 2/8/12 9:00am

Collins Stewart Downgrades Morgan Stanley from Buy to Hold, Raises PT to $23 2/8/12 5:30am

Glam Media picking bankers for IPO 2/7/12 3:31pm

Brightcove chooses NASDAQ for IPO 2/7/12 5:00am

Finally, Good News from Citigroup 2/6/12 1:10pm

European Stocks Down on Greek Austerity 2/6/12 7:27am

Three Bullish Signs for Today's Market 2/3/12 8:35am

Greenway grows in NYSE IPO [PHOTOS] 2/2/12 4:20pm

Facebook Follows Netscape and Google as a Generation-Defining Internet IPO: Should We Care? 2/2/12 11:45am

Facebook Picks Morgan Stanley to Lead IPO; Exchange Listing Still Up In The Air 2/1/12 2:42pm

Facebook IPO Could be Way Smaller Than Expected 2/1/12 10:09am

Financial Sector Top Performers in January 2/1/12 6:52am

UPDATE: Collins Stewart Downgrades Morgan Stanley to Hold 2/8/12

Collins Stewart Downgrades Morgan Stanley from Buy to Hold, Raises PT to $23 2/8/12

Glam Media picking bankers for IPO 2/7/12

Brightcove chooses NASDAQ for IPO 2/7/12

Finally, Good News from Citigroup 2/6/12

European Stocks Down on Greek Austerity 2/6/12

Three Bullish Signs for Today's Market 2/3/12

Greenway grows in NYSE IPO [PHOTOS] 2/2/12

Facebook Follows Netscape and Google as a Generation-Defining Internet IPO: Should We Care? 2/2/12

Facebook Picks Morgan Stanley to Lead IPO; Exchange Listing Still Up In The Air 2/1/12

Facebook IPO Could be Way Smaller Than Expected 2/1/12

Financial Sector Top Performers in January 2/1/12

European Stocks Down on Greek Austerity 2/6/12

Three Bullish Signs for Today's Market 2/3/12

Financial Sector Top Performers in January 2/1/12

Goldman Sachs Downgrades Bank of America; Shares Fall 3% 1/30/12

Short J.C. Penney on Price Change News 1/25/12

How to Trade the 2012 State of the Union Speech 1/24/12

Negative CPI, Positive Job Numbers. Is the Economy Healing or Not? 1/19/12

Positive Jobless Claims Move Equities Higher. Will the Trend Last? 1/19/12

US Dollar Continues to Plummet 1/19/12

Stocks To Watch For January 19 1/19/12

Stocks to Watch Thursday 1/19/12

Is Morgan Soaring Ahead of Itself? 1/18/12

UPDATE: Collins Stewart Downgrades Morgan Stanley to Hold 2/8/12

Collins Stewart Downgrades Morgan Stanley from Buy to Hold, Raises PT to $23 2/8/12

Morgan Stanley Trading At Session Lows Despite Goldman Upgrade 1/30/12

Goldman Sachs Downgrades Bank of America; Shares Fall 3% 1/30/12

UPDATE: Goldman Sachs Upgrades Morgan Stanley to Conviction Buy 1/30/12

Short J.C. Penney on Price Change News 1/25/12

UPDATE: J.P. Morgan Downgrades Morgan Stanley and Goldman Sachs to Neutral Rating 1/25/12

JP Morgan Downgrades Morgan Stanley to Neutral 1/25/12

Dick Bove is Bullish on Bank of America; Should You Listen? 1/20/12

Oppenheimer Maintains Outperform on Morgan Stanley After Weak Quarter 1/19/12

Is Morgan Soaring Ahead of Itself? 1/18/12

End-of-Day Market Summary for January 13, 2012 1/13/12

Trade MS
NOW!

Partner Headlines

Good Times and Bad, Goldman Employees Get the Cash, Shareholders Not So Much 2/13/12

Stocks Logged Weekly Loss amid Greek Drama 2/11/12

Morgan Stanley: Financial Loser 2/10/12

The Worst IPO Peddling Isn't Social Media 2/10/12

Morgan Stanley: Financial Loser 2/10/12

The Worst IPO Peddling Isn't Social Media 2/10/12

Bank Stocks Get Upgrades: Morgan Stanley, UBS 2/9/12

Bankers Will Still Get Their Billions Despite Clawbacks 2/9/12

Bank Stocks Get Upgrades: Morgan Stanley, UBS 2/9/12

Clawbacks Will Leave Minor Scratches on Wall Street 2/9/12

Stocks Gained Amid Greek Drama 2/8/12

'Mad Money Lightning Round': Get Some Covidien 2/8/12

Press Releases

Research and Markets: Protein and Peptide Mass Spectrometry in Drug Discovery 2/9/12 Business Wire Story

Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 2/9/12 Business Wire Story

Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference 2/9/12 Business Wire Story

Opexa Therapeutics to Present at the 14th Annual BIO CEO & Investor Conference 2/8/12 Business Wire Story

Elan Reports Fourth Quarter and Full-Year 2011 Financial Results 2/8/12 Business Wire Story

Avanir Pharmaceuticals Reports Fiscal 2012 First Quarter Financial and Business Results 2/7/12 Newswire Story

Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference 2/7/12 Business Wire Story

Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES® 2/6/12 Business Wire Story

Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke 2/3/12 Business Wire Story

Experimental Neurology Journal: BrainStorm's NurOwn™ Stem Cell Technology Shows Promise for Treating Huntington's Disease 2/1/12 Business Wire Story

MediciNova Receives a Notice of Patent Allowance for a Method of Treating Progressive Multiple Sclerosis 2/1/12 GlobeNewswire Story

Morgan Stanley Smith Barney Account Statement Ranks #1 for Second Consecutive Year 1/31/12 Business Wire Story

Get the latest MS stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Morgan Stanley stock price.

Morgan Stanley by YCharts

Morgan Stanley (MS) 19.67 -0.68

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On MS

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social